Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

Paul M. McKeigue; David A. McAllister; Jen Bishop; Sharon Hutchinson; Chris Robertson; Nazir Lone; Jim McMenamin; David Goldberg; Helen M. Colhoun

doi:10.12688/f1000research.53812.1

Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

Paul M. McKeigue, David A. McAllister, Jen Bishop, Sharon Hutchinson, Chris Robertson, Nazir Lone, Jim McMenamin, David Goldberg, Helen M. Colhoun

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
文章编号	663
期刊	F1000Research
卷	10
DOI	https://doi.org/10.12688/f1000research.53812.1
出版状态	已出版 - 2021
已对外发布	是

!!!ASJC Scopus Subject Areas

一般生物化学、遗传与分子生物学
一般免疫学和微生物学
药理学、毒理学和药学（全部）

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.12688/f1000research.53812.1

其它文件与链接

引用此

@article{f880ec8aaedb48928c19ff0d7644ecb0,

title = "Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland",

author = "McKeigue, {Paul M.} and McAllister, {David A.} and Jen Bishop and Sharon Hutchinson and Chris Robertson and Nazir Lone and Jim McMenamin and David Goldberg and Colhoun, {Helen M.}",

note = "Funding Information: No specific funding was received for this study. Professor Colhoun is supported by an endowed chair from the AXA Research Foundation. Publisher Copyright: Copyright: {\textcopyright} 2021 McKeigue PM et al.",

year = "2021",

doi = "10.12688/f1000research.53812.1",

language = "English",

volume = "10",

journal = "F1000Research",

issn = "2046-1402",

publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

AU - McKeigue, Paul M.

AU - McAllister, David A.

AU - Bishop, Jen

AU - Hutchinson, Sharon

AU - Robertson, Chris

AU - Lone, Nazir

AU - McMenamin, Jim

AU - Goldberg, David

AU - Colhoun, Helen M.

N1 - Funding Information: No specific funding was received for this study. Professor Colhoun is supported by an endowed chair from the AXA Research Foundation. Publisher Copyright: Copyright: © 2021 McKeigue PM et al.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85153033784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85153033784&partnerID=8YFLogxK

U2 - 10.12688/f1000research.53812.1

DO - 10.12688/f1000research.53812.1

M3 - Article

AN - SCOPUS:85153033784

SN - 2046-1402

VL - 10

JO - F1000Research

JF - F1000Research

M1 - 663

ER -

Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此